查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1542501

全球癌症免疫療法藥物發現外包市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Cancer Immunotherapy Drug Discovery Outsourcing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 164 Pages | 商品交期: 最快1-2個工作天內

價格

全球癌症免疫療法藥物發現外包市場的需求預計將從2023年的15.1億美元達到2032年近37.4億美元的市場規模，2024-2032年研究期間的複合年成長率為10.56%。

癌症免疫治療藥物發現外包包括與外部公司簽約以進行與癌症免疫治療相關的研發活動。這種外包模式使製藥和生技公司能夠利用內部可能無法獲得的專業知識、技術和資源。該過程包括臨床前研究、臨床試驗和開發新型免疫治療劑，旨在利用人體的免疫系統來靶向和消除癌細胞。透過外包這些活動，公司可以加速藥物開發、降低成本並更有效地管理風險。這種策略方法有助於獲得尖端技術和專業知識，同時允許組織在競爭激烈的癌症治療領域中專注於其核心能力和策略目標。

市場動態

由於開發新型癌症免疫療法的複雜性和成本不斷增加，癌症免疫療法藥物發現外包市場正在經歷大幅成長。外包為製藥和生物技術公司提供了對成功發現和開發這些療法至關重要的專業知識和先進技術。透過與經驗豐富的合約研究組織 (CRO) 和其他服務提供者合作，公司可以簡化藥物發現流程、縮短上市時間並更有效地管理成本。人們越來越重視免疫療法作為癌症治療的革命性方法，這也推動了癌症免疫療法藥物發現外包市場的成長。免疫療法利用人體的免疫系統來靶向癌細胞，在臨床試驗中顯示出有希望的結果，並且正在成為首選的治療方式。這一趨勢推動了對外包服務的需求，這些服務可以加速新免疫療法藥物的開發並提高臨床試驗效率。

此外，CAR-T 細胞療法和檢查點抑制劑等免疫治療技術的進步為外包合作夥伴關係創造了新的機會。開發這些尖端治療方法需要專業知識和基礎設施，這使得外包對許多公司具有吸引力。另一個積極的市場趨勢是製藥公司和外包提供者之間的合作和策略聯盟數量不斷增加。這些合作關係使公司能夠獲得更多資源和專業知識，促進更有效率和有效的藥物發現過程。然而，智慧財產權和資料安全問題可能會抑制癌症免疫治療藥物發現外包市場的成長。與外包相關的風險，包括潛在的智慧財產權竊盜和資料洩露，可能會影響公司參與外包安排的意願並影響整體市場動態。

這項詳細的市場研究以從多個來源獲得的資料為中心，並使用多種工具進行分析，包括波特五力分析、市場吸引力分析和價值鏈分析。這些工具用於深入了解市場的潛在價值，為業務策略家提供最新的成長機會。此外，這些工具還提供了全球癌症免疫療法藥物發現外包市場中每個應用/產品細分的詳細分析。

市場區隔

廣泛的癌症免疫治療藥物發現外包市場已細分為藥物類型、服務類型和癌症類型。該報告根據地理細分研究了這些子集。策略師可以獲得詳細的洞察並針對特定市場制定適當的策略。這些細節將導致採取有針對性的方法，從而識別更好的機會。

依藥物類型

  • 單株抗體
  • 免疫調節劑
  • 溶瘤病毒療法和癌症疫苗
  • 其他

按服務類型

  • 目標識別和驗證
  • 鉛篩選與表徵
  • 基於細胞的檢測

按癌症類型

  • 肺
  • 胸部
  • 大腸直腸
  • 黑色素瘤
  • 攝護腺
  • 頭部和頸部
  • 卵巢
  • 胰
  • 區域分析
  • 此外，該報告還包括地理細分，主要關注北美、歐洲、亞太地區、拉丁美洲以及中東和非洲地區當前和預測的癌症免疫療法藥物發現外包需求。該報告進一步關注所有地區對各個應用領域的需求。
  • 該報告還涵蓋了詳細的競爭格局，包括在全球市場上營運的主要參與者的公司簡介。癌症免疫療法藥物發現外包市場的主要參與者包括Aquila BioMedical、BPS Bioscience, Inc.、Celentyx Ltd.、Covance, Inc.、Crown Bioscience, Inc.、DiscoverX Corporation、Explicyte、Genscript Biotech Corporation、HD Biosciences Co.、 Ltd.、Horizo​​n Discovery Group PLC、ImmunXperts SA、Molecular Imaging, Inc.、Personalis, Inc.、Promega Corporation 和STC Biologics。深入了解競爭前景，包括未來產能、關鍵併購、財務概況、合作夥伴關係、合作、新產品發布、新產品開發和其他發展，並提供總部資訊

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 癌症免疫療法藥物發現外包市場亮點
  • 全球癌症免疫療法藥物發現外包市場概況

第 3 章：癌症免疫治療藥物發現外包 - 產業分析

  • 介紹
  • 癌症免疫治療藥物發現外包市場的市場促進因素
  • 癌症免疫治療藥物發現外包市場的市場約束
  • 癌症免疫療法藥物發現外包市場的機會
  • 癌症免疫療法藥物發現外包市場趨勢
  • 波特對癌症免疫療法藥物發現外包市場的五力分析
  • 癌症免疫療法藥物發現外包市場吸引力分析
    • 按藥物類型分類的市場吸引力分析
    • 按服務類型分類的市場吸引力分析
    • 按癌症類型分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 癌症免疫治療藥物發現外包價值鏈分析
  • 癌症免疫治療藥物發現外包原料分析
    • 原料清單
    • 癌症免疫療法藥物研發外包原料廠商名單
    • 癌症免疫療法藥物發現外包關鍵原料價格趨勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球癌症免疫療法藥物發現外包市場分析：按藥物類型

  • 按藥物類型概述
  • 按藥物類型分類的全球癌症免疫療法藥物發現外包市場分析
  • 單株抗體市場分析：按地區
  • 免疫調節劑市場分析：按地區
  • 溶瘤病毒療法和癌症疫苗的市場分析：按地區
  • 其他市場分析：按地區

第 6 章：全球癌症免疫療法藥物發現外包市場分析：按服務類型

  • 按服務類型概述
  • 按服務類型分類的全球癌症免疫療法藥物發現外包市場分析
  • 目標識別和驗證的市場分析：按地區
  • 鉛篩選和表徵的市場分析：按地區
  • 細胞檢測市場分析：按地區

第 7 章：全球癌症免疫療法藥物發現外包市場分析：按癌症類型

  • 按癌症類型概述
  • 按癌症類型分類的全球癌症免疫療法藥物發現外包市場分析
  • 肺臟市場分析：按地區
  • 乳房市場分析：按地區
  • 大腸直腸市場分析：按地區
  • 黑色素瘤市場分析：按地區
  • 攝護腺市場分析：按地區
  • 頭頸部市場分析：按地區
  • 卵巢市場分析：按地區
  • 胰臟市場分析：按地區

第 8 章：全球癌症免疫療法藥物發現外包市場分析：按地理位置

  • 區域展望
  • 介紹
  • 北美洲
    • 概述
    • 北美癌症免疫療法藥物發現外包市場估計：按國家/地區
    • 美國
    • 北美其他地區
  • 歐洲
    • 概述
    • 歐洲癌症免疫治療藥物發現外包市場估計：按細分市場
    • 歐洲癌症免疫療法藥物發現外包市場估計：按國家/地區
    • 英國
    • 法國
    • 德國
    • 歐洲其他地區
  • 亞太地區
    • 概述
    • 亞太地區癌症免疫治療藥物發現外包市場估計：按細分市場
    • 亞太地區癌症免疫治療藥物發現外包市場估計：按國家/地區
    • 中國
    • 日本
    • 印度
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲癌症免疫治療藥物發現外包市場估計：按細分市場
    • 拉丁美洲癌症免疫療法藥物發現外包市場估計：按國家/地區
    • 巴西
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲癌症免疫療法藥物發現外包市場估計：按細分市場
    • 中東和非洲癌症免疫療法藥物發現外包市場估計：按國家/地區
    • 中東
    • 非洲

第 9 章：癌症免疫療法藥物發現外包公司的競爭格局

  • 癌症免疫療法藥物發現外包市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 10 章：公司簡介

  • 公司股份分析
  • 市場集中度
  • Aquila BioMedical
    • 公司概況
    • 產品
    • 最新動態
  • BPS Bioscience, Inc.
    • 公司概況
    • 產品
    • 最新動態
  • Celentyx Ltd.
    • 公司概況
    • 產品
    • 最新動態
  • Covance, Inc.
    • 公司概況
    • 產品
    • 最新動態
  • Crown Bioscience, Inc.
    • 公司概況
    • 產品
    • 最新動態
  • DiscoverX Corporation
    • 公司概況
    • 產品
    • 最新動態
  • Explicyte
    • 公司概況
    • 產品
    • 最新動態
  • Genscript Biotech Corporation
    • 公司概況
    • 產品
    • 最新動態
  • HD Biosciences Co., Ltd.
    • 公司概況
    • 產品
    • 最新動態
  • Horizon Discovery Group PLC
    • 公司概況
    • 產品
    • 最新動態
  • ImmunXperts SA
    • 公司概況
    • 產品
    • 最新動態
  • Molecular Imaging, Inc.
    • 公司概況
    • 產品
    • 最新動態
  • Personalis, Inc.
    • 公司概況
    • 產品
    • 最新動態
  • Promega Corporation
    • 公司概況
    • 產品
    • 最新動態
  • STC Biologics
    • 公司概況
    • 產品
    • 最新動態

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

Product Code: VMR11211227

The global demand for Cancer Immunotherapy Drug Discovery Outsourcing Market is presumed to reach the market size of nearly USD 3.74 Billion by 2032 from USD 1.51 Billion in 2023 with a CAGR of 10.56% under the study period 2024 - 2032.

Cancer immunotherapy drug discovery outsourcing includes contracting external firms to conduct research and development activities related to immunotherapy treatments for cancer. This outsourcing model allows pharmaceutical and biotechnology companies to leverage specialized expertise, technologies, and resources that may not be available in-house. The process includes preclinical research, clinical trials, and developing novel immunotherapeutic agents designed to harness the body's immune system to target & eliminate cancer cells. By outsourcing these activities, companies can accelerate drug development, reduce costs, and manage risks more effectively. This strategic approach facilitates access to cutting-edge technologies and expertise while allowing organizations to focus on their core competencies and strategic objectives in the highly competitive field of cancer therapeutics.

MARKET DYNAMICS

The cancer immunotherapy drug discovery outsourcing market is experiencing substantial growth driven by the increasing complexity and cost of developing novel cancer immunotherapies. Outsourcing provides pharmaceutical and biotechnology companies access to specialized expertise and advanced technologies crucial for successfully discovering and developing these therapies. By partnering with experienced contract research organizations (CROs) and other service providers, companies can streamline their drug discovery processes, reduce time-to-market, and manage costs more effectively. The growing emphasis on immunotherapy as a revolutionary approach to cancer treatment is also fuelling cancer immunotherapy drug discovery outsourcing market growth. Immunotherapy, which leverages the body's immune system to target cancer cells, has shown promising results in clinical trials and is becoming a preferred treatment modality. This trend drives demand for outsourcing services that can accelerate the development of new immunotherapeutic agents and enhance clinical trial efficiency.

Furthermore, advancements in immunotherapy technologies, such as CAR-T cell therapy and checkpoint inhibitors, create new opportunities for outsourcing partnerships. The need for specialized knowledge and infrastructure to develop these cutting-edge treatments makes outsourcing attractive for many companies. Another positive market trend is the increasing number of collaborations and strategic alliances between pharmaceutical companies and outsourcing providers. These partnerships enable companies to access more resources and expertise, facilitating more efficient and effective drug discovery processes. However, intellectual property and data security concerns may restrain cancer immunotherapy drug discovery outsourcing market growth. Risks associated with outsourcing, including potential IP theft and data breaches, can impact the willingness of companies to engage in outsourcing arrangements and affect overall market dynamics.

This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter's five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of cancer immunotherapy drug discovery outsourcing.

Market Segmentation

The broad cancer immunotherapy drug discovery outsourcing market has been sub-grouped into drug type, service type, and cancer type. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.

By Drug Type

  • Monoclonal Antibodies
  • Immunomodulators
  • Oncolytic Viral Therapies And Cancer Vaccines
  • Others

By Service Type

  • Target Identification And Validation
  • Lead Screening And Characterization
  • Cell Based Assays

By Cancer Type

  • Lung
  • Breast
  • Colorectal
  • Melanoma
  • Prostate
  • Head And Neck
  • Ovarian
  • Pancreatic
  • Regional Analysis
  • Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for cancer immunotherapy drug discovery outsourcing in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
  • The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the cancer immunotherapy drug discovery outsourcing market includes Aquila BioMedical, BPS Bioscience, Inc., Celentyx Ltd., Covance, Inc., Crown Bioscience, Inc., DiscoverX Corporation, Explicyte, Genscript Biotech Corporation, HD Biosciences Co., Ltd., Horizon Discovery Group PLC, ImmunXperts SA, Molecular Imaging, Inc., Personalis, Inc., Promega Corporation and STC Biologics. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Cancer Immunotherapy Drug Discovery Outsourcing Market
  • 2.2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Snapshot

3 . CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING - INDUSTRY ANALYSIS

  • 3.1. Introduction
  • 3.2. Market Drivers of Cancer Immunotherapy Drug Discovery Outsourcing Market
  • 3.3. Market Restraints of Cancer Immunotherapy Drug Discovery Outsourcing Market
  • 3.4. Opportunities of Cancer Immunotherapy Drug Discovery Outsourcing Market
  • 3.5. Trends of Cancer Immunotherapy Drug Discovery Outsourcing Market
  • 3.6. Porter's Five Force Analysis of Cancer Immunotherapy Drug Discovery Outsourcing Market
  • 3.7. Cancer Immunotherapy Drug Discovery Outsourcing Market Attractiveness Analysis
    • 3.7.1 Market Attractive Analysis by Drug Type
    • 3.7.2 Market Attractive Analysis by Service Type
    • 3.7.3 Market Attractive Analysis by Cancer Type
    • 3.7.4 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Cancer Immunotherapy Drug Discovery Outsourcing Value Chain Analysis
  • 4.2. Cancer Immunotherapy Drug Discovery Outsourcing Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Cancer Immunotherapy Drug Discovery Outsourcing Raw Material Manufactures List
    • 4.2.3. Price Trend of Cancer Immunotherapy Drug Discovery Outsourcing Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY DRUG TYPE

  • 5.1 Overview by Drug Type
  • 5.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type
  • 5.3 Market Analysis of Monoclonal Antibodies by Regions
  • 5.4 Market Analysis of Immunomodulators by Regions
  • 5.5 Market Analysis of Oncolytic Viral Therapies And Cancer Vaccines by Regions
  • 5.6 Market Analysis of Others by Regions

6 . GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY SERVICE TYPE

  • 6.1 Overview by Service Type
  • 6.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Service Type
  • 6.3 Market Analysis of Target Identification And Validation by Regions
  • 6.4 Market Analysis of Lead Screening And Characterization by Regions
  • 6.5 Market Analysis of Cell Based Assays by Regions

7 . GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY CANCER TYPE

  • 7.1 Overview by Cancer Type
  • 7.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Cancer Type
  • 7.3 Market Analysis of Lung by Regions
  • 7.4 Market Analysis of Breast by Regions
  • 7.5 Market Analysis of Colorectal by Regions
  • 7.6 Market Analysis of Melanoma by Regions
  • 7.7 Market Analysis of Prostate by Regions
  • 7.8 Market Analysis of Head And Neck by Regions
  • 7.9 Market Analysis of Ovarian by Regions
  • 7.10. Market Analysis of Pancreatic by Regions

8 . GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America
    • 8.3.1. Overview
    • 8.3.2. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country
    • 8.3.3. United State
    • 8.3.4. Rest of North America
  • 8.4. Europe
    • 8.4.1. Overview
    • 8.4.2. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Market Segment
    • 8.4.3. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country
    • 8.4.4. United Kingdom
    • 8.4.5. France
    • 8.4.6. Germany
    • 8.4.7 Rest of Europe
  • 8.5. Asia Pacific
    • 8.5.1. Overview
    • 8.5.2. Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Market Segment
    • 8.5.3. Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country
    • 8.5.4. China
    • 8.5.5. Japan
    • 8.5.6. India
    • 8.5.7. Rest of Asia Pacific
  • 8.6. Latin America
    • 8.6.1. Overview
    • 8.6.2. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Market Segment
    • 8.6.3. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country
    • 8.6.4. Brazil
    • 8.6.5. Rest of Latin America
  • 8.7. Middle East & Africa
    • 8.7.1. Overview
    • 8.7.2. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Market Segment
    • 8.7.3. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country
    • 8.7.4. Middle East
    • 8.7.5. Africa

9 . COMPETITIVE LANDSCAPE OF THE CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING COMPANIES

  • 9.1. Cancer Immunotherapy Drug Discovery Outsourcing Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Aquila BioMedical
    • 10.3.1. Company Overview
    • 10.3.2. Financials
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. BPS Bioscience, Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financials
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Celentyx Ltd.
    • 10.5.1. Company Overview
    • 10.5.2. Financials
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Covance, Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financials
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. Crown Bioscience, Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financials
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. DiscoverX Corporation
    • 10.8.1. Company Overview
    • 10.8.2. Financials
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. Explicyte
    • 10.9.1. Company Overview
    • 10.9.2. Financials
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. Genscript Biotech Corporation
    • 10.10.1. Company Overview
    • 10.10.2. Financials
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. HD Biosciences Co., Ltd.
    • 10.11.1. Company Overview
    • 10.11.2. Financials
    • 10.11.3. Products
    • 10.11.4. Recent Developments
  • 10.12. Horizon Discovery Group PLC
    • 10.12.1. Company Overview
    • 10.12.2. Financials
    • 10.12.3. Products
    • 10.12.4. Recent Developments
  • 10.13. ImmunXperts SA
    • 10.13.1. Company Overview
    • 10.13.2. Financials
    • 10.13.3. Products
    • 10.13.4. Recent Developments
  • 10.14. Molecular Imaging, Inc.
    • 10.14.1. Company Overview
    • 10.14.2. Financials
    • 10.14.3. Products
    • 10.14.4. Recent Developments
  • 10.15. Personalis, Inc.
    • 10.15.1. Company Overview
    • 10.15.2. Financials
    • 10.15.3. Products
    • 10.15.4. Recent Developments
  • 10.16. Promega Corporation
    • 10.16.1. Company Overview
    • 10.16.2. Financials
    • 10.16.3. Products
    • 10.16.4. Recent Developments
  • 10.17. STC Biologics
    • 10.17.1. Company Overview
    • 10.17.2. Financials
    • 10.17.3. Products
    • 10.17.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Global Market Snapshot
  • Drivers of the Global Market Impact Analysis
  • Restraints of the Global Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Monoclonal Antibodies by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Immunomodulators by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Oncolytic Viral Therapies And Cancer Vaccines by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Others by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Service Type (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Target Identification And Validation by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Lead Screening And Characterization by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Cell Based Assays by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Cancer Type (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Lung by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Breast by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Colorectal by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Melanoma by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Prostate by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Head And Neck by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Ovarian by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Pancreatic by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market by Geography (USD MN)
  • North America Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • North America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • North America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • North America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country (USD MN)
  • United State Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • United State Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • United State Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Cancer Type (USD MN)
  • Rest of North America Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Rest of North America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Rest of North America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type(USD MN)
  • Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • United Kingdom Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • United Kingdom Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • United Kingdom Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • France Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • France Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • France Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Germany Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Germany Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Germany Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Rest of Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Rest of Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Rest of Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country (USD MN)
  • China Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • China Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • China Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • India Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • India Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • India Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Rest of Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Rest of Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Rest of Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country (USD MN)
  • Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Rest of Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Rest of Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Rest of Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country (USD MN)
  • Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis

LIST OF FIGURES

  • Research Scope of Cancer Immunotherapy Drug Discovery Outsourcing Report
  • Market Research Process
  • Market Research Methodology
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Drug Type
  • Market Attractiveness Analysis by Service Type
  • Market Attractiveness Analysis by Cancer Type
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Monoclonal Antibodies by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Immunomodulators by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Oncolytic Viral Therapies And Cancer Vaccines by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Others by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Service Type (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Target Identification And Validation by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Lead Screening And Characterization by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Cell Based Assays by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Cancer Type (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Lung by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Breast by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Colorectal by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Melanoma by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Prostate by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Head And Neck by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Ovarian by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Pancreatic by Geography (USD MN)
  • Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market by Revenue
  • Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market by Revenue
  • Recent Development in Cancer Immunotherapy Drug Discovery Outsourcing Industry
  • Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.